<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010083797">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Cerapio, J. P.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Perrier, M.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Pont, F.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Tosolini, M.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Laurent, C.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Bertani, Stéphane</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Fournie, J. J.</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Single-cell RNAseq profiling of human gamma delta T lymphocytes in virus-related cancers and COVID-19 disease</title>
        <secondary-title>Viruses</secondary-title>
      </titles>
      <pages>2212 [14 p.]</pages>
      <keywords>
        <keyword>human</keyword>
        <keyword>gammadelta</keyword>
        <keyword>lymphocyte</keyword>
        <keyword>tumor</keyword>
        <keyword>COVID-19</keyword>
        <keyword>transcriptome</keyword>
        <keyword>single cell</keyword>
        <keyword>differentiation</keyword>
        <keyword>trajectory</keyword>
      </keywords>
      <dates>
        <year>2021</year>
      </dates>
      <call-num>fdi:010083797</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>Viruses</full-title>
      </periodical>
      <accession-num>ISI:000726850600001</accession-num>
      <number>11</number>
      <electronic-resource-num>10.3390/v13112212</electronic-resource-num>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010083797</url>
        </related-urls>
        <pdf-urls>
          <url>https://horizon.documentation.ird.fr/exl-doc/pleins_textes/2022-01/010083797.pdf</url>
        </pdf-urls>
      </urls>
      <volume>13</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>The detailed characterization of human gamma delta T lymphocyte differentiation at the single-cell transcriptomic (scRNAseq) level in tumors and patients with coronavirus disease 2019 (COVID-19) requires both a reference differentiation trajectory of gamma delta T cells and a robust mapping method for additional gamma delta T lymphocytes. Here, we incepted such a method to characterize thousands of gamma delta T lymphocytes from (n = 95) patients with cancer or adult and pediatric COVID-19 disease. We found that cancer patients with human papillomavirus-positive head and neck squamous cell carcinoma and Epstein-Barr virus-positive Hodgkin's lymphoma have gamma delta tumor-infiltrating T lymphocytes that are more prone to recirculate from the tumor and avoid exhaustion. In COVID-19, both TCRV gamma 9 and TCRV gamma non9 subsets of gamma delta T lymphocytes relocalize from peripheral blood mononuclear cells (PBMC) to the infected lung tissue, where their advanced differentiation, tissue residency, and exhaustion reflect T cell activation. Although severe COVID-19 disease increases both recruitment and exhaustion of gamma delta T lymphocytes in infected lung lesions but not blood, the anti-IL6R therapy with Tocilizumab promotes gamma delta T lymphocyte differentiation in patients with COVID-19. PBMC from pediatric patients with acute COVID-19 disease display similar gamma delta T cell lymphopenia to that seen in adult patients. However, blood gamma delta T cells from children with the COVID-19-related multisystem inflammatory syndrome are not lymphodepleted, but they are differentiated as in healthy PBMC. These findings suggest that some virus-induced memory gamma delta T lymphocytes durably persist in the blood of adults and could subsequently infiltrate and recirculate in tumors.</abstract>
      <custom6>050 ; 052 ; 020</custom6>
      <custom1>UR152</custom1>
    </record>
  </records>
</xml>
